Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5% hypertonic saline plus Ventolin versus 0.9% saline plus Ventolin for moderate asthma attack in children
IRCT20230930059568N1Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of salbutamol, hypertonic saline and Normal Saline-Benha University in asthma (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoints: Improvement in dyspnea, Improvement in retractions and 4 more. Started Nov 2023; status: completed.
02
Drugs
salbutamolhypertonic salineNormal Saline-Benha University
03
Conditions
asthma
Beyond the preview
Go deeper on IRCT20230930059568N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230930059568N1.